GHRP Peptides (GHRP-2, GHRP-6, Hexarelin): Complete Research Guide - Ghrelin Mimetics and GH Secretagogues

Peptide Research Guide | 2026-05-03 | 14 min read

Complete research guide to GHRP peptides covering ghrelin receptor agonism, GH secretion mechanisms, differences between GHRP-2, GHRP-6, and Hexarelin, dosing protocols, and combination strategies.

Introduction to GHRP Research

Growth Hormone-Releasing Peptides (GHRPs) represent a major advancement in GH enhancement therapy. These synthetic ghrelin mimetics directly activate the ghrelin receptor, providing a powerful stimulus for growth hormone release. Understanding their pharmacology enables optimal use in research applications.

Ghrelin Biology

Ghrelin Physiology

The Hunger Hormone:

  • Produced primarily in stomach
  • Only known peripherally-secreted orexigenic hormone
  • Binds to ghrelin receptor (GHSR-1a)
  • Drives hunger and GH release

Ghrelin Effects: | Effect | Mechanism | |--------|-----------| | Hunger | Hypothalamic signaling | | GH release | Direct pituitary action | | Appetite | NPY/AgRP neurons | | Sleep | REM promotion |

Ghrelin Receptor (GHSR-1a)

Receptor Characteristics:

  • G-protein coupled receptor (Gq/11)
  • High expression in hypothalamus and pituitary
  • Activates phospholipase C pathway
  • Increases intracellular calcium

GHRP Peptide Family

First Generation GHRPs

GHRP-2:

  • Hexapeptide
  • Highest selectivity for GH release
  • Minimal appetite effects
  • Molecular weight: 817 Da

GHRP-6:

  • Hexapeptide
  • Stronger appetite stimulation
  • More prolonged GH release
  • Molecular weight: 873 Da

Second Generation GHRPs

Hexarelin:

  • Hexarelin = Hexarelin
  • Most potent in family
  • Some cardiac effects
  • Faster receptor desensitization
  • Molecular weight: 878 Da

Comparative Analysis

Receptor Binding

Binding Affinities: | Peptide | GHSR-1a Affinity | Selectivity | |---------|-----------------|-------------| | GHRP-2 | High | Most selective | | GHRP-6 | High | Some appetite | | Hexarelin | Highest | Potent, downregulation |

Ghrelin vs Synthetic GHRPs

Natural Ghrelin:

  • Requires octanoyl modification for activity
  • Short half-life (~10-15 minutes)
  • Potent but transient effect

Synthetic GHRPs:

  • No modification required
  • Extended half-life
  • More stable binding
  • Higher receptor affinity

Mechanism of Action

Ghrelin Receptor Activation

Signal Transduction: $GHRP \\rightarrow GHSR-1a\\ activation \\rightarrow G_q \\rightarrow PLC \\uparrow \\rightarrow IP_3 \\uparrow + DAG \\uparrow \\rightarrow \\uparrow Ca^{2+} \\rightarrow GH\\ release$

GH Release Pathway

Direct Pituitary Action: | Step | Process | |------|---------| | 1 | GHRP binds GHSR-1a | | 2 | Gq-mediated signaling | | 3 | Intracellular calcium increase | | 4 | GH granule exocytosis | | 5 | GH release |

Comparison with GHRH

Complementary Pathways:

| Pathway | GHRP | GHRH | |---------|------|------| | Receptor | GHSR-1a | GHRH-R | | Signal | Gq → PLC → Ca²⁺ | Gs → cAMP → PKA | | Gate | Unlocks | Opens | | Combined | Both effects | Both effects |

Clinical Research Evidence

GH Release Studies

Single-Dose Studies:

GHRP-2: | Dose | GH Peak | Duration | |------|---------|----------| | 60 mcg/kg | 20-30 ng/mL | 2-3 hours | | 120 mcg/kg | 40-60 ng/mL | 3-4 hours |

GHRP-6: | Dose | GH Peak | Duration | |------|---------|----------| | 60 mcg/kg | 25-35 ng/mL | 3-4 hours | | 120 mcg/kg | 45-70 ng/mL | 4-5 hours |

Body Composition Effects

Long-term Studies: | Parameter | Effect | Duration | |-----------|--------|----------| | Lean mass | +2-4 kg | 3-6 months | | Body fat | -2-4% | 3-6 months | | IGF-1 | +20-50% | 2-4 weeks | | Strength | +10-25% | 3-6 months |

Dosing Protocols

GHRP-2 Protocol

Standard Dosing: | Parameter | Recommendation | |-----------|---------------| | Dose | 100-200 mcg | | Frequency | 1-3x daily | | Route | SC injection | | Timing | Before meals (optional) |

High-Dose Protocol: | Parameter | Recommendation | |-----------|---------------| | Dose | 200-300 mcg | | Frequency | 1-2x daily | | Notes | May increase side effects |

GHRP-6 Protocol

Standard Dosing: | Parameter | Recommendation | |-----------|---------------| | Dose | 100-200 mcg | | Frequency | 1-2x daily | | Notes | Stronger appetite effect |

Hexarelin Protocol

Standard Dosing: | Parameter | Recommendation | |-----------|---------------| | Dose | 100-150 mcg | | Frequency | 1-2x daily | | Notes | Desensitization risk |

Cycling with Hexarelin:

  • Use 4-8 weeks on, 4 weeks off
  • Prevents receptor downregulation
  • Maintains responsiveness

Combination Strategies

GHRP + GHRH (CJC-1295)

Synergistic Stack: | Peptide | Dose | Frequency | |---------|------|-----------| | GHRP-2 or GHRP-6 | 100-200 mcg | 1-2x daily | | CJC-1295 | 100-300 mcg | 1-2x daily |

Rationale:

  • GHRP: Unlocks pituitary
  • CJC-1295: Opens pituitary
  • Combined: Maximum GH release
  • More physiological pattern

Full GH Stack

Comprehensive Protocol: | Peptide | Dose | Timing | |---------|------|--------| | CJC-1295 | 200-300 mcg | Morning + evening | | GHRP-2 or GHRP-6 | 100-200 mcg | Morning + evening |

Notes:

  • Simulates exercise GH pulses
  • Enhanced anabolic effects
  • Synergistic mechanisms

Side Effects and Management

Common Side Effects

Appetite Effects: | Peptide | Appetite Increase | |---------|-----------------| | GHRP-2 | Mild | | GHRP-6 | Moderate-high | | Hexarelin | Moderate |

Water Retention:

  • Dose-dependent
  • Usually transient
  • More common initially
  • Manageable with lower doses

Hormone Effects

Cortisol and Prolactin: | Hormone | Effect | Clinical Significance | |---------|--------|----------------------| | Cortisol | Mild elevation | Transient | | Prolactin | Possible elevation | Monitor if persistent |

Receptor Desensitization

Hexarelin-Specific:

  • GH receptor downregulation possible
  • Mitigate with cycling
  • Break periods essential
  • Less concern with GHRP-2

Research Applications

Anabolic Research

Muscle Building:

  • Protein synthesis
  • Nitrogen retention
  • Satellite cell activation
  • Recovery enhancement

Metabolic Research

Fat Loss:

  • Increased lipolysis
  • Enhanced fatty acid oxidation
  • Metabolic rate increase
  • Insulin sensitivity

Recovery Research

Tissue Repair:

  • Injury recovery
  • Post-surgical healing
  • Training recovery
  • Connective tissue repair

Comparison Summary

| Property | GHRP-2 | GHRP-6 | Hexarelin | |----------|--------|--------|-----------| | Potency | High | High | Highest | | Selectivity | Best | Good | Moderate | | Appetite | Mild | High | Moderate | | Desensitization | Slow | Moderate | Fast | | PRL effect | Mild | Moderate | Higher | | Cardiac effects | None | None | Some |

Analytical Methods

GH Measurement

Monitoring Approach:

  • IGF-1: Primary marker
  • GH: Pulsatile, variable
  • IGFBP-3: Secondary marker

Sampling Schedule:

  • Pre-dose baseline
  • Post-dose peaks (15, 30, 45, 60 min)
  • IGF-1: Every 4 weeks

Conclusion

GHRP peptides offer powerful GH stimulation through ghrelin receptor agonism. Their unique mechanisms—particularly when combined with GHRH analogs like CJC-1295—provide comprehensive activation of the GH axis. Understanding the differences between GHRP-2, GHRP-6, and Hexarelin enables optimized research applications.

---

Research Disclaimer: This guide provides information for research purposes. GHRP peptides are investigational compounds. Research use must follow appropriate guidelines.

References: Ghrelin literature; GHRP pharmacology research; growth hormone secretagogue studies.

ZePeptide content is for lawful laboratory and in-vitro research sourcing. Products are not supplied for human or veterinary use.

Research peptide catalogSupplier checklistMore peptide guides